93 results
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
29 Mar 24
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
5:19pm
contracts for rapid susceptibility testing, reflecting customers’ commitment to Accelerate rapid AST technology and interest in Wave.
Net Sales were
8-K
EX-10.1
AXDX
Accelerate Diagnostics Inc
24 Jan 24
Entry into a Material Definitive Agreement
9:20pm
and oral, among the parties, with respect to the subject matter hereof, including any commitment letter entered into relating to the subject matter hereof
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
customers to multi-year contracts for rapid susceptibility testing, reflecting customers’ commitment to Accelerate rapid AST technology and interest … is paid through a commitment by the customer to purchase minimum quantities of reagents and test kits over a period of time. Accordingly, we must either
S-1/A
EX-1.1
6gm svwh5g
16 Jan 24
IPO registration (amended)
7:18am
S-1/A
otkpitb9
16 Jan 24
IPO registration (amended)
7:18am
8-K
EX-99.1
o0bkk3
8 Jan 24
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
6:03am
S-1
zo6hm 6hl6ej8x
13 Dec 23
IPO registration
5:30pm
8-K
j0gb6eaaul
13 Dec 23
December 2023 Company Presentation
5:05pm
8-K
EX-10.1
zhpm 8g34jxrioop
13 Dec 23
December 2023 Company Presentation
5:05pm
8-K
EX-99.1
09jfk vd3
10 Aug 23
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results
4:10pm
8-K
EX-10.8
avlfohl8v
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-99.1
55je5
29 Mar 23
Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results
4:21pm